We are live on ! Find out more
CNSY

Cerenome, Inc. Common Stock

14 hedge funds and large institutions have $4.11M invested in Cerenome, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

473% more capital invested

Capital invested by funds: $718K → $4.11M (+$3.4M)

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

75% more funds holding

Funds holding: 814 (+6)

0.01% more ownership

Funds ownership: 0.01%0.02% (+0.01%)

Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
4
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

CNSY Hedge Fund Activity: Q2 2021 in Review

14 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Cerenome, Inc. Common Stock (CNSY) for Q2 2021, worth a combined $4.11M — up 473% from $718K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CNSY positions and 3 closed out — a net gain of 6 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.53M. The largest seller was B. Riley Wealth Management, exiting entirely with an estimated $29K sold.

  • 14 institutional investors held Cerenome, Inc. Common Stock (CNSY) as of Q2 2021, up from 8 in Q1 2021.
  • Funds reported $4.11M of Cerenome, Inc. Common Stock stock for Q2 2021, up 473% quarter-over-quarter.
  • 9 funds opened new Cerenome, Inc. Common Stock positions in Q2 2021 and 3 closed out, a net change of +6 holders.
  • The largest Cerenome, Inc. Common Stock buyer in Q2 2021 was Vanguard Group, an estimated $1.53M added.
  • The largest Cerenome, Inc. Common Stock seller in Q2 2021 was B. Riley Wealth Management, an estimated $29K sold.

Based on aggregated 13F filings for Q2 2021.